Skip to main navigationSkip to main content
The University of Southampton
OLIGOMED - Oligonucleotides for medical applications

Dr. Krzysztof Kucharczyk

Krzysztof Kucharczyk

Dr. Krzysztof Kucharczyk is CEO of BioVectis.

__________

Privacy Settings